title: TGF-beta1 and endothelial/tissue injury with high-dose intravenous iron therapy in renal failure: evidence or perception?
authors.forename: Joanna
authors.initials: J
authors.lastname: Goździkiewicz
authors.forename: Jacek
authors.initials: J
authors.lastname: Borawski
authors.forename: Beata
authors.initials: B
authors.lastname: Naumnik
authors.forename: Alicja
authors.initials: A
authors.lastname: Rydzewska-Rosołowska
authors.forename: Krystyna
authors.initials: K
authors.lastname: Pawlak
authors.forename: Michał
authors.initials: M
authors.lastname: Myśliwiec
mesh_terms: D004730:Endothelium, Vascular / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage* / Q000009:adverse effects; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy*; D016212:Transforming Growth Factor beta / Q000097:blood / Q000502:physiology*; D053773:Transforming Growth Factor beta1
chemical_list: C508960:TGFB1 protein, human; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D007501:Iron